| Stage | RS | % of rev | YSWY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.2B | 100.00% | $921M | 100.00% | RS ×5.66 |
| Gross profit | $1.5B | 27.89% | $122M | 13.22% | RS +14.7pp |
| Operating income | $552M | 10.59% | $48M | 5.19% | RS +5.4pp |
| Pre-tax income | $532M | 10.20% | $36M | 3.89% | RS +6.3pp |
| Net income | $403M | 7.74% | $30M | 3.22% | RS +4.5pp |
| Stage | RS | YSWY | Gap · A − B |
|---|---|---|---|
| Revenue | $5.2B100.00% | $921M100.00% | RS ×5.66 |
| Gross profit | 27.89%$1.5B | 13.22%$122M | RS +14.7pp |
| Operating income | 10.59%$552M | 5.19%$48M | RS +5.4pp |
| Pre-tax income | 10.20%$532M | 3.89%$36M | RS +6.3pp |
| Net income |
| 7.74%$403M |
| 3.22%$30M |
| RS +4.5pp |
None
No disclosed counterparties: RS.